From mechanism to management: CEREMAST perspectives on the intersection of HαT and clonal mast cell disorders
{{output}}
Since its initial description ten years ago, numerous studies have contributed to a better understanding of the role of hereditary alpha-tryptasemia (HαT) in the diagnosis and management of patients with clonal mast cell activation disorders (cMCADs). These s... ...
